The agency has approved a four-dose version of the drug, called Mounjaro KwikPen, which provides a month’s course of GLP-1 and GIP agonist tirzepatide. Great Britain will be the first major ...
Eli Lilly, in particular, aims to launch Mounjaro in a delivery device called KwikPen outside the U.S., leveraging existing manufacturing resources to meet demand. Additionally, the development of ...